Edition:
United States

Marrone Bio Innovations Inc (MBII.OQ)

MBII.OQ on NASDAQ Stock Exchange Capital Market

2.15USD
7 Dec 2016
Change (% chg)

$-0.12 (-5.29%)
Prev Close
$2.27
Open
$2.26
Day's High
$2.28
Day's Low
$2.13
Volume
51,327
Avg. Vol
17,495
52-wk High
$2.78
52-wk Low
$0.62

MBII.OQ

Chart for MBII.OQ

About

Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate... (more)

Overall

Beta: 0.47
Market Cap(Mil.): $55.97
Shares Outstanding(Mil.): 24.66
Dividend: --
Yield (%): --

Financials

  MBII.OQ Industry Sector
P/E (TTM): -- 18.81 16.68
EPS (TTM): -1.40 -- --
ROI: -64.54 6.77 8.74
ROE: -- 9.58 10.66

BRIEF-Marrone Bio Innovations' Majestene bionematicide approved in California

* Marrone Bio Innovations receives California approval for Majestene bionematicide Source text for Eikon: Further company coverage:

Nov 16 2016

BRIEF-Marrone Bio Innovations Q3 revenue $3.6 mln

* Qtrly total GAAP revenues for Q3 of 2016 up by 46.8% to $3.6 million

Nov 14 2016

BRIEF-Marrone Bio says Mexico regulatory authorities approve GRANDEVO, VENERATE for sale

* Mexico regulatory authorities have approved for sale both of company's bioinsecticides, grandevo and venerate Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jul 26 2016

BRIEF-Marrone Bio Innovations - Regalia Rx Biofungicide approved in Canada

* Regalia RX Biofungicide approved in Canada for use on wheat and soybeans Source text for Eikon: Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)

Jul 14 2016

Competitors

Earnings vs. Estimates